Nome Químico: Methyl 2-(3-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl)phenyl)-2-methylpropanoate
Sorrisos: OC(C1=CC=CC=C1)(C2=CC=CC=C2)C3CCN(CCCC(C4=CC(C(C)(C)C(OC)=O)=CC=C4)O)CC3
Inchi: InChI=1S/C24H21N3O4S2/c25-17-1-9-21(10-2-17)32(28,29)23-13-5-19(6-14-23)27-20-7-15-24(16-8-20)33(30,31)22-11-3-18(26)4-12-22/h1-16,27H,25-26H2
Separation of Fexofenadine, Pseudoephedrine, Potential Impurities, and Degradation Products Using Ion Interaction Chromatography
Thomas A. Walker Gary L. Schmitt
Journal of Liquid Chromatography & Related Technologies, 29: 25–43, 2006
Simultaneous determination of fexofenadine and its related compounds by HPLC
T. Radhakrishna a , G. Om Reddy
Journal of Pharmaceutical and Biomedical Analysis 29 (2002) 681–690
Novel Preparation of H1 Receptor Antagonist Fexofenadine
Jun Huang,†,‡ Wen Wang,† and Li-Xin Wang
Organic Process Research & Development 2010, 14, 1464–1468
Development of validated stability-indicating chromatographic method for the determination of fexofenadine hydrochloride and its related impurities in pharmaceutical tablets
Hadir M Maher, Maha A Sultan & Ileana V Olah
Chemistry Central Journal volume 5, Article number: 76 (2011)